Hypertrophic Cardiomyopathy - A Heterogeneous and Lifelong Disease in the Real World -

被引：25

作者：

Kitaoka, Hiroaki ^{[1
]}

Kubo, Toru ^{[1
]}

Doi, Yoshinori L. ^{[2
]}

机构：

[1] Kochi Univ, Kochi Med Sch, Dept Cardiol & Geriatr, 185-1 Kohasu,Oko Cho, Nankoku, Kochi 7838505, Japan

[2] Chikamori Hosp, Cardiomyopathy Inst, Kochi, Japan

来源：

CIRCULATION JOURNAL | 2020年 / 84卷 / 08期

关键词：

Genetics; Hypertrophic cardiomyopathy; Left ventricular modeling; BRAIN NATRIURETIC PEPTIDE; SUDDEN-DEATH RISK; SYMPTOMATIC PATIENTS; ATRIAL-FIBRILLATION; EUROPEAN-SOCIETY; CLINICAL-COURSE; TASK-FORCE; PHENOTYPE; MANAGEMENT; DIAGNOSIS;

D O I：

10.1253/circj.CJ-20-0524

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hypertrophic cardiomyopathy (HCM) is the most frequent hereditary cardiomyopathy, showing an autosomal-dominant f inheritance. A great deal of attention has been paid to genetics, left ventricular tract obstruction and the prediction and prevention of sudden cardiac death in HCM. Needless to say, these are very important, but we should recognize the heterogeneity in etiology, morphology, clinical course and management of this unique cardiomyopathy. Another important perspective is that HCM causes left ventricular remodeling over time and is a disease that requires lifelong management in the real world.

引用

页码：1218 / 1226

页数：9

共 62 条

[1]

Alfares AA, 2015, GENET MED, V17, P880, DOI [10.1038/gim.2014.205, 10.1038/gim.2015.16]

[2] Characterization of a Phenotype-Based Genetic Test Prediction Score for Unrelated Patients With Hypertrophic Cardiomyopathy [J].

Bos, J. Martijn ;

Will, Melissa L. ;

Gersh, Bernard J. ;

Kruisselbrink, Teresa M. ;

Ommen, Steve R. ;

Ackerman, Michael J. .

MAYO CLINIC PROCEEDINGS, 2014, 89 (06) :727-737

[3] Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy [J].

Burke, Michael A. ;

Cook, Stuart A. ;

Seidman, Jonathan G. ;

Seidman, Christine E. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (25) :2871-2886

[4] Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy [J].

Chan, Raymond H. ;

Maron, Barry J. ;

Olivotto, Iacopo ;

Pencina, Michael J. ;

Assenza, Gabriele Egidy ;

Haas, Tammy ;

Lesser, John R. ;

Gruner, Christiane ;

Crean, Andrew M. ;

Rakowski, Harry ;

Udelson, James E. ;

Rowin, Ethan ;

Lombardi, Massimo ;

Cecchi, Franco ;

Tomberli, Benedetta ;

Spirito, Paolo ;

Formisano, Francesco ;

Biagini, Elena ;

Rapezzi, Claudio ;

De Cecco, Carlo Nicola ;

Autore, Camillo ;

Cook, E. Francis ;

Hong, Susie N. ;

Gibson, C. Michael ;

Manning, Warren J. ;

Appelbaum, Evan ;

Maron, Martin S. .

CIRCULATION, 2014, 130 (06) :484-495

[5] Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy [J].

Coats, Caroline J. ;

Gallagher, Mathew J. ;

Foley, Michael ;

OMahony, Constantinos ;

Critoph, Christopher ;

Gimeno, Juan ;

Dawnay, Anne ;

McKenna, William J. ;

Elliott, Perry M. .

EUROPEAN HEART JOURNAL, 2013, 34 (32) :2529-2537

[6] Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation [J].

Dominguez, Fernando ;

Climent, Vicente ;

Zorio, Esther ;

Ripoll-Vera, Tomas ;

Salazar-Mendiguchia, Joel ;

Manuel Garcia-Pinilla, Jose ;

Angel Urbano-Moral, Jose ;

Fernandez-Fernandez, Xusto ;

Lopez-Cuenca, David ;

Ajo-Ferrer, Raquel ;

Sanz-Sanchez, Jorge ;

Gomez-Perez, Yolanda ;

Lopez-Garrido, Miguel A. ;

Barriales-Villa, Roberto ;

Ramon Gimeno, Juan ;

Garcia-Pavia, Pablo .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 :232-238

[7] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].

Elliott, Perry M. ;

Anastasakis, Aris ;

Borger, Michael A. ;

Borggrefe, Martin ;

Cecchi, Franco ;

Charron, Philippe ;

Hagege, Albert Alain ;

Lafont, Antoine ;

Limongelli, Giuseppe ;

Mahrholdt, Heiko ;

McKenna, William J. ;

Mogensen, Jens ;

Nihoyannopoulos, Petros ;

Nistri, Stefano ;

Pieper, Petronella G. ;

Pieske, Burkert ;

Rapezzi, Claudio ;

Rutten, Frans H. ;

Tillmanns, Christoph ;

Watkins, Hugh .

EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+

[8] Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy [J].

Elliott, Perry M. ;

Gimeno, Juan R. ;

Tome, Maria T. ;

Shah, Jaymin ;

Ward, Deirdre ;

Thaman, Rajesh ;

Mogensen, Jens ;

McKenna, William J. .

EUROPEAN HEART JOURNAL, 2006, 27 (16) :1933-1941

[9] 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J].

Gersh, Bernard J. ;

Maron, Barry J. ;

Bonow, Robert O. ;

Dearani, Joseph A. ;

Fifer, Michael A. ;

Link, Mark S. ;

Naidu, Srihari S. ;

Nishimura, Rick A. ;

Ommen, Steve R. ;

Rakowski, Harry ;

Seidman, Christine E. ;

Towbin, Jeffrey A. ;

Udelson, James E. ;

Yancy, Clyde W. .

CIRCULATION, 2011, 124 (24) :2761-+

[10]

Geske JB, 2016, J AM COLL CARDIOL, V61, p2456

← 1 2 3 4 5 6 7 →